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PROTHIOCONAZOLE TOLERANT 
CRYPT 0C 0C C US FLAVESCENS STRAINS 
FOR BIOLOGICAL CONTROL OF 
FUSARIUM HEAD BLIGHT 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The invention is draWn to novel biocontrol agents for con 
trol of Fusarium head blight. 
2. Description of the Prior Art 
Fusarium head blight (FHB) is a devastating disease of 
Wheat and barley throughout the semi-humid and humid 
cereal producing regions of the World (McMullen et al., 1997, 
Scab of Wheat and barley: are emerging disease of devastating 
impact. Plant Disease, 81, 1340-1348; Muthomi et al., 2002, 
Susceptibility of Kenyan Wheat varieties to head blight, fun 
gal invasion and deoxynivalenol accumulation inoculated 
With Fusarium graminearum, Journal of Phytopathology, 
150, 30-36; Yu. Gagkaeva and Yli-Mattila, 2004, Genetic 
diversity of Fusarium graminearum in Europe and Asia, 
European Journal of Plant Pathology, 110, 551-562). FHB is 
caused primarily by F usarium graminearum SchWabe Group 
2 (Aoki and O’Donnell, 1999, Morphological and molecular 
characterization of Fusarium pseudograminearum sp. nov., 
formerly recogniZed as the Group 1 population of F 
graminearum, Mycologia, 91, 597-609) [perfect 
state:Gibberella zeae (SchWein.) Fetch]. In addition to caus 
ing grain yield loss, G. zeae can produce mycotoxins such as 
the estrogenic toxin Zearalenone (F-2) (Hesseltine et al., 
1978, Fungi, especially Gibberella zeae, and Zearalenone 
occurrence in Wheat. Mycologia, 70, 14-18) and the trichoth 
ecene deoxynivalenol (DON, vomitoxin) (Snijders, 1990, 
Fusarium head blight and mycotoxin contamination of 
Wheat, a revieW. Netherlands Journal of Plant Pathology, 96, 
187-198) that can have a deleterious effect on grain quality 
[CardWell et al., 2001, Mycotoxins: the cost of achieving food 
security and food quality, APS Net: Feature story August, 
2001] and animal health [Marasas, 1991, Toxigenic Fusaria, 
in: Mycotoxins and Animal Foods, J. E. Smith and R. S. 
Henderson, eds., CRC Press, Inc., Boca Raton, Fla.; Beardall 
and Miller, 1994, Diseases in humans With mycotoxins as 
possible causes, in Mycotoxins in Grain: Compounds Other 
thanA?atoxin (MILLER, J. D. & TRENHOLM, H. L., Eds.). 
Eagan Press, St. Paul, Minn., pp. 387-39; Pestka and Bondy, 
1994, Immunotoxic effects of mycotoxins, in Mycotoxins in 
Grain: Compounds Other than A?atoxin (MILLER, J. D. & 
TRENHOLM, H. L., Eds.) Eagan Press, St. Paul, Minn., pp. 
339-358]. 
Reducing the impact of FHB on grain production and qual 
ity remains an intractable problem. Fungicides sometimes 
have reduced FHB [Wilcoxson, 1996, Fungicides for control 
of Fusarium head blight, Int. J. Tropical Plant Disease, 14, 
27-50; Suty and Mauler-Machnik, 1997, Fusarium ear blight 
on Wheat-epidemiology and control of Gibberella zeae, the 
teleomorph of F usarium graminearum With Folicur, in Diag 
nosis and Identi?cation of Plant Pathogens, Proceedings of 
the 4th International Symposium of the European Foundation 
for Plant Pathology (DEHNE, H. W., ADAM, G., DIEK 
MANN, M., FRAHM, J ., MAULER-MACHNIK & VAN 
HALTEREN, P., Eds). KluWer Academic Publishers, Dor 
drecht., pp. 243-246; Jones, 1999, Seedling blight develop 
ment and control in spring Wheat damaged by Fusarium 
graminearum Group 2. Plant Disease, 83, 1013-1018], but 
residues, reports of fungicide resistance and instances of 
DON content increases in grain can be concerns With theiruse 
[Mauler-Machnik and Zahn, 1994, Ear fusarioses in Wheat 
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neW ?ndings on their epidemiology and control With Folicur 
(tebuconaZole). P?anZenschutZ-Nachrichten Bayer, 47, 129 
155; RamireZ et al., 2004, Impact of environmental factors 
and fungicides on groWth and deoxynivalenol production by 
Fusarium graminearum isolates from Argentinian Wheat. 
Crop Protection, 23, 117-125; Chen et al, 2000, Recent 
advances in Wheat head scab research in China, in Proc. Int. 
Symp. Wheat Improvement for Scab Resistance (RAUPP, W. 
J ., MA, Z., CHEN, P. & LIU, D., Eds.). Nanjing Agricultural 
University, Jiangsu, China, pp. 258-273; Gale et al, 2002, 
Population analysis of Fusarium graminearum from Wheat 
?elds in eastern China, Phytopathology, 92, 1315-1322]. 
Although the development of resistant cultivars or anatomi 
cally altered varieties (LegZdina and Buerstmayr, 2004, Com 
parison of infection With F usarium head blight and accumu 
lation of mycotoxins in grain of hulless and covered barley, 
Journal of Cereal Science, 40, 61-67) of small grains holds 
promise in reducing FHB, highly resistant cultivars With ideal 
agronomic traits have not been developed (Johnston, 1994; 
Bushnell et al., 1998, Genetic engineering of disease resis 
tance in cereals, Canadian Journal of Plant Pathology, 20, 
137-149; Bai et al., 2000, Inheritance of resistance to 
Fusarium graminearum in Wheat, Theoretical and Applied 
Genetics, 100, 1-8). The genetic diversity of G. zeae 
[O’Donnell et al., 2004, Genealogical concordance betWeen 
the mating type locus and seven other nuclear genes supports 
formal recognition of nine phylogenetically distinct species 
Within the Fusarium graminearium Glade, Fungal Genetics 
and Biology, 41, 600-623; McCallum et al., 2004, Barrage 
Zone formation betWeen vegetatively incompatible F usarium 
graminearum (Gibberella zeae) isolates. Phytopathology, 94, 
432-437; Walker et al., 2001, Variation among isolates of 
Fusarium graminearum associated With Fusarium head 
blight in North Carolina, Plant Disease, 85, 404-410; Cuma 
gun et al., 2004, Genetic mapping of pathogenicity and 
aggressiveness of Gibberella zeae (Fusarium graminearum) 
toWard Wheat, Phytopathology, 94, 520-526] raises concerns 
regarding hoW durable the ef?cacy of fungicides and resistant 
cultivars Will be. Conventional tillage of ?elds is partially 
effective in reducing pathogen inoculum production and, 
concomitantly, FHB (Miller et al., 1998, Effect of tillage 
practice on F usarium head blight of Wheat, Canadian Journal 
of Plant Pathology, 20, 95-103; Dill-Macky and Jones, 2000, 
The effect of previous crop residues and tillage on Fusarium 
head blight of Wheat, Plant Disease, 84, 71-76; Pereyra et al., 
2004, Survival and inoculum production of Gibberella zeae 
in Wheat residue, Plant Disease, 88, 724-730), but minimum 
tillage is the preferred agricultural practice for soil conserva 
tion. Considering the potential of long distance inoculum 
dispersal and the diverse crops that can act as alternative hosts 
of the pathogen (Chongo et al., 2001, Reaction of seedling 
roots of 14 crop species to Fusarium graminearum from 
Wheat head, Canadian Journal of Plant Pathology, 23, 132 
137), crop rotation is an untenable solution. 
Biological control of FHB has attracted considerable inter 
est since the mid 1990’s, and signi?cant advances have been 
achieved [Perondi et al., 1996, Controle microbiologico da 
giberela do trigo, Fitopatologia Brasiliera, 21, 243-249; 
Bujold et al., 2001, Effect of Microsphaeropsis sp. on the 
production of perithecia and ascospores of Gibbereila zeae, 
Plant Disease, 85, 977-984; Schisler et al., 2002, Biological 
control of F usarium head blight of Wheat and deoxynivalenol 
levels in grain via use of microbial antagonists, in Mycotoxins 
and Food Safety (DeVRIES, J. W., TRUCKSESS, M. W. & 
JACKSON, L. S., Eds.). KluWer Academic/Plenum Publish 
ers, NeW York, pp. 53-69; da LuZ et al, 2003, Biological 
control of F usarium graminearum, in F usarium head blight 
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of Wheat and barley (LEONARD, K. J. & BUSHNELL, W. 
R., Eds.) APS Press, St. Paul, Minn., 381-394; Gilbert & 
Fernando. 2004, Epidemiology and biological control of Gib 
berella zeae (anamorph Fusarium graminearum). Canadian 
Journal of Plant Pathology, 26, 1-9]. Public acceptance, com 
patibility With other disease management measures, and 
durability are all favorable factors in support of developing 
strategies for biologically controlling FHB. 
Schisler et al. (US. Pat. No. 6,562,337) described the iso 
lation of four yeast and one bacterium Which Were superior 
antagonists capable of suppressing FHB. These microorgan 
isms, Which Were obtained from the anthers of Wheat, 
included the yeast Cryplococcus?avescens OH 182.9 (origi 
nally classi?ed as C. nodaensis) Which Was deposited in the 
Agricultural Research Service Culture Collection (N RRL) 
under deposit accession no. NRRL Y-30216. Recently, 
Schisler et al. (2006, Selection and evaluation of the potential 
of choline-metabolizing microbial strains to reduce F usari um 
head blight, Biological Control, 39, 497-506) disclosed 
selecting choline-utiliZing strains of microorganisms as bio 
logical control agents against FHB. 
Although efforts for developing biological control agents 
for FHB have been effective, the development and use of 
chemical fungicides remain a valuable tool in the arsenal of 
agents for the reduction of FHB in cereals. Most recently the 
fungicidal chemical prothioconaZole has received an exemp 
tion status for use on Wheat at ?owering for the reduction of 
FHB. 
HoWever, despite these and other advances, the need 
remains for improved microorganisms for use in the biologi 
cal control of FHB. 
SUMMARY OF THE INVENTION 
We have noW discovered novel strains of Cryplococcus 
?avescens Which are superior antagonists of F graminearum. 
These microorganisms are effective for suppression and con 
trol of FHB in cereals, particularly in Wheat and barley. The 
strains of the invention are prothioconaZole tolerant variants 
of previously described C. ?avescens OH 182.9 (N RRL 
Y-30216). Moreover, these prothioconaZole tolerant variants 
surprisingly exhibit signi?cantly increased e?icacy against E 
graminearum in comparison to the parent strain OH 182.9. 
In accordance With this discovery, it is an object of this 
invention to provide novel microbial strains that suppress the 
profusion of F graminearum in heads of Wheat and barley. 
Another object of this invention is to provide novel micro 
bial strains Which are effective for the suppression of F 
graminearum in heads of Wheat and barley, and Which are 
also tolerant to the fungicide prothioconaZole. 
A further object of this invention is to provide novel micro 
bial strains Which are effective for the control of F 
graminearum in heads of Wheat and barley Which can be 
applied in concert With the fungicide prothioconaZole and its 
derivatives . 
This and other objects of the invention Will become readily 
apparent from the ensuing description. 
DEPOSIT OF BIOLOGICAL MATERIAL 
TWo prothioconaZole tolerant strains of Cryplococcus?a 
vescens, OH 182.9 variant 3C and OH 182.9 variant 4C, have 
been deposited on May 21, 2010 under the provisions of the 
Budapest Treaty in the Agricultural Research Service Culture 
Collection (NRRL), 1815 N. University St., Peoria, Ili, 
61604, USA, and have been as signed Deposit Acces sion Nos. 
NRRLY-50378 and NRRLY-50379, respectively. The strains 
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are yeasts Which exhibit morphological and cultural proper 
ties characteristic of Cij/plococcus?avescens, and their iden 
tity has been con?rmed by sequence analysis of the D1/D2 
domains of the 26S rRNA gene and the ITS 1+2 regions of the 
rRNA gene using standard methods (Okoli et al., 2006, Cryp 
lolrichosporon anacardii gen. nov., sp. nov., a neW trichos 
poronoid capsulate basidiomycetous yeast from Nigeria that 
is able to form melanin on niger seed agar. FEMS Yeast Res, 
7:339-350). The phylogenetic tree Was constructed using 
neighbor joining With the uncorrected ('p') substitution 
model, alignment gaps Were treated as missing characters, 
and all characters Were unordered and of equal Weight. Boot 
strap values Were based on 100 replicates. 
DETAILED DESCRIPTION OF THE INVENTION 
For purposes of this invention it is understood that the use 
of term F usarium is intended to include both the sexual (te 
leomorphic) stage of this organism and also the asexual (an 
amorphic) stage, also referred to as the perfect and imperfect 
fungal stages, respectively. For example, the anamorphic 
stage of Gibberella zeae is knoWn as F usarium graminearum, 
the causative agent of FHB. This disease results When the 
?oWer or head (also knoWn as seed head) becomes inoculated 
With conidia produced by the imperfect form OR ascospores 
produced by the perfect form of this fungus With infection of 
the inoculated head ensuing after the inoculation event. 
The expression “superior antagonist” used herein in refer 
ence to a microorganism is intended to mean that the subject 
strain exhibits a degree of inhibition of Fusarium-induced 
head blight exceeding, at a statistically signi?cant level, that 
of an untreated control. 
The term cereal as used herein is intended to refer to any 
cereal species that is normally susceptible to FHB. Cereals 
reported to be susceptible include Wheat, barley, oats, and 
triticale, though Wheat and barley are the tWo crops in Which 
this disease presents a signi?cant economic problem. Any of 
these cereals may be target species for FHB control. 
F graminearum primarily infects the heads (?oWer heads, 
seed heads, or spikes) of cereal plants from the time of How 
ering through the soft dough stage of head development. 
Germinated conidia or ascospores of E graminearum pen 
etrate through anthers and associated tissues to initiate infec 
tion of the host and the development of symptoms of FHB. 
The E graminearum antagonists of this invention are vari 
ant strains derived from Cryplococcus?avescens OH 182.9 
(N RRL Y-30216, formerly identi?ed as C. nodaensis) Which 
Was previously described in US. Pat. No. 6,562,337, the 
contents of Which are incorporated by reference herein. 
Although C. ?avescens OH 182.9 is effective in reducing 
FHB in cereals, unfortunately it is sensitive even to loW con 
centrations of the fungicide prothioconaZole. This sensitivity 
has limited the application of the C. ?avescens against FHB in 
?elds Which are or Will also be treated With prothioconaZole. 
We have noW discovered that variants or mutants of C. ?ave 
scensOH 182.9 Which exhibit signi?cantly greater tolerance 
to prothioconaZole (capable of groWth in the presence of 
prothioconaZole) than the parent OH 182.9 may be produced. 
Moreover, We have surprisingly discovered that at least some 
of the prothioconaZole tolerant strains are superior antago 
nists to F graminearum, and exhibit signi?cantly greater 
e?icacy against FHB than the parent C. ?avescens OH 182.9. 
The prothioconaZole tolerant strains of the invention are 
produced using a protracted series of culturing events Where 
the yeast is exposed to increasing concentrations of prothio 
conaZole. As described in greater detail in the Example, the 
parent C. ?avescens OH 182.9 is cultivated in a nutrient 
US 8,241,889 B2 
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medium containing between at least a trace concentration up 
to about 4 ppm prothioconaZole, preferably about 1 ppm 
prothioconaZole, and strains exhibiting growth are selected 
for culture at higher concentrations of prothioconaZole. The 
process is repeated With the selected strains cultivated at 
gradually increasing concentrations of the fungicide to ulti 
mately select strains capable of groWth in nutrient media 
containing betWeen at least about 2 ppm up to about 10 ppm 
prothioconaZole, preferably about 5 ppm prothioconaZole. 
Recovered prothioconaZole tolerant C. ?avescens strains 
are subsequently examined for e?icacy in reducing the sever 
ity of FHB in a desired cereal plant, preferably Wheat. In brief, 
the prothioconaZole tolerant variants are passed through a 
plant bioassay in Which cells of the yeasts are introduced to a 
cereal plant seed head inoculated With conidia of F 
graminearum. In one preferred embodiment, the F 
graminearum Will be produced on a solidi?ed groWth 
medium and the level of harvested inoculum should be on the 
order of about 10“-106 conidia/ml, preferably about 105 
conidia/ml of aqueous suspension. The cells of prothiocona 
Zole tolerant yeast antagonist in medium or a suitable buffer 
are introduced at a level of approximately 107-108 cfu/ml. In 
one embodiment of the invention, the conidia of F 
graminearum and cells of the test strain are combined in a 
Weak phosphate buffer and approximately 10 pL of the sus 
pension are used to inoculate the plant seed head. The plants 
are then cultivated under conditions of near 100% relative 
humidity conducive to infection by the fungus for a period of 
about 3 days. After a period of time su?icient for noticeable 
development of the disease (usually at least about 2 Weeks 
post inoculation), yeast variants used to treat seed heads and 
that reduce visible symptoms of FHB are selected for subse 
quent evaluation. 
ProthioconaZole tolerant yeast variants selected in the 
plant bioassay described above are optionally subjected to a 
second, more highly replicated plant seed head bioassay simi 
lar to the ?rst. The yeast are again groWn on a suitable medium 
until suf?ciently expanded for use in the bioassay. HoWever, 
in this second plant bioassay, it is preferable to groW the 
strains in liquid culture since this practice is Widely used in 
industry and, antagonists must shoW bioef?cacy When groWn 
under liquid culture conditions. ColoniZed broth containing 
cells of individual strains and a conidial suspension of F 
graminearum are used to inoculate seed heads as previously 
described. The cells and conidial suspension may be precom 
bined prior to inoculation. As in the ?rst plant bioassay, yeast 
variants used to treat seed heads and that reduce visible symp 
toms of FHB are selected as candidate antagonists. 
Con?rmation of antagonist ef?cacy in controlling F 
graminearum canbe made in scaled-up greenhouse studies or 
in ?eld studies in Which ?oWering plants are treated With cells 
of the test strains, before, during, or after inoculation With 
conidia of F graminearum. The plant treatment can be con 
ducted in the same manner as a bona ?de ?eld application. 
ProthioconaZole tolerant variants of OH 182.9 are deter 
mined to be superior to the Wild type OH 182.9 progenitor 
strain if, When progenitor and variant line cells are produced 
using comparable liquid culture groWth techniques, the pro 
thioconaZole tolerant variants reduce disease severity symp 
toms by at least 50% or at least 25% more than the progenitor 
strain in replicated greenhouse or ?eld trials on Wheat, respec 
tively. Disease severity is determined by calculating the aver 
age percentage of the surface area of individual Wheat heads 
that exhibit symptoms of infection by F graminearum. 
Using the aforementioned method We have isolated tWo 
novel prothioconaZole tolerant strains of superior FHB 
antagonist: Cryplocaccus ?avescens, OH 182.9 variant 3C 
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and OH 182.9 variant 4C. It is envisioned that the method may 
be repeated to isolate additional prothioconaZole tolerant 
variants of C. ?avescens OH 182.9 Which exhibit signi?cantly 
greater e?icacy in reducing FHB in cereal plants. 
The prothioconaZole tolerant variants of C. ?avescens OH 
182.9 Will typically be groWn in aerobic liquid cultures on 
media Which contain sources of carbon, nitrogen, and inor 
ganic salts assimilable by the microorganism and supportive 
of ef?cient cell groWth. Preferred carbon sources are hexoses 
such as glucose, but other assimilable sources such as amino 
acids, may be substituted. Many inorganic and proteinaceous 
materials may be used as nitrogen sources in the groWth 
process. Preferred nitrogen sources are amino acids and urea 
but others include gaseous ammonia, inorganic salts of nitrate 
and ammonium, vitamins, purines, pyrimidines, yeast 
extract, beef extract, proteose peptone, soybean meal, 
hydrolysates of casein, distiller’s solubles, and the like. 
Among the inorganic minerals that can be incorporated into 
the nutrient medium are the customary salts capable of yield 
ing calcium, Zinc, iron, manganese, magnesium, copper, 
cobalt, potassium, sodium, molybdate, phosphate, sulfate, 
chloride, borate, and like ions. 
For the yeast of the invention, cell groWth can be achieved 
at temperatures betWeen 1 and 36° C., With the preferred 
temperature being in the range of 15-300 C. The pH of the 
nutrient medium can vary betWeen 4 and 9, but the preferred 
operating range is pH 6-8. Ordinarily, maximal cell yield is 
obtained in 20-72 hours after inoculation. 
As described in greater detail hereinbeloW, control of FHB 
may be effected by application of one or more of the prothio 
conaZole tolerant variants of C. ?avescens OH 182.9 to the 
head (also referred to as seed head) of a cereal plant. As used 
herein, the “head” or “seed head” refers to the spike that 
contains seeds or the progenitors of seeds. The antagonists are 
applied in an amount effective to reduce the level of FHB 
relative to that in an untreated control. 
Although the above-mentioned prothioconaZole tolerant 
variants are effective When used alone, in an optional yet 
preferred embodiment, they are applied in combination With 
other knoWn chemical or biological control agents for FHB. 
As noted above, oWing to their tolerance to prothioconaZole, 
the variants may be applied in combination With prothiocona 
Zole or its derivatives. Alternatively, the variants may be 
applied to cereal plants Which have been or Will be treated 
separately With prothioconaZole or its derivatives. A variety 
of other biological control agents are suitable for use herein 
and include but are not limited to those disclosed by Perondi 
et al., 1996, ibid; Bujold et al., 2001, ibid; Schisler et al., 2002, 
ibid; da LuZ et al., 2003, ibid; Gilbert & Fernando, 2004, ibid; 
and Schisler et al., U.S. Pat. Nos. 6,562,337 and 6,312,940, 
and Us. application Ser. No. 11/640,091, ?led Dec. 15, 2006; 
the contents of all of Which are incorporated by reference 
herein. Use in combination With the microbial antagonists 
disclosed in the Schisler U.S. patents and pending application 
is preferred, speci?cally Bacillus sp. (NRRL B-30210), 
Bacillus sp. (NRRL B-30211), Tarula aurea (recently 
renamed Cryplocaccus aureus)(NRRL Y-30213), an uniden 
ti?ed yeast (NRRL Y-30214), Bacillus sp. (NRRL B-30212), 
and Tarula sp. (recently renamed Cryplococcus aureus)(N 
RRL Y-30215). These additional antagonists may be applied 
With the antagonists of the invention, such as in a mixture, or 
they may be applied separately or at different times. 
The prothioconaZole tolerant variants of the invention can 
be applied by any conventional method to the surfaces of 
cereal heads. For example, they can be applied as an aqueous 
spray, as a Wettable poWder, or as a dust. Formulations 
designed for these modes of application Will usually include 
US 8,241,889 B2 
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a suitable liquid or solid carrier together With other adjuvants, 
such as Wetting agents, sticking agents and the like. Starch, 
polysaccharides, sodium alginate, cellulose, etc. are, often 
used in such formulations as carriers and sticking agents. 
The expressions “an effective amount” and “a suppressive 
amount” are used herein in reference to that quantity of 
antagonist treatment Which is necessary to obtain a reduction 
in the level of disease relative to that occurring in an untreated 
control under suitable conditions of treatment as described 
herein. The actual rate of application of a liquid formulation 
Will usually vary from a minimum of about 1><103 to about 
1><101O viable cells/ml and preferably from about 1><106 to 
about 5><109 viable cells/ml. Under most conditions, the 
strains of the invention described in the example, beloW, 
Would be optimally effective at application rates in the range 
ofabout 1><106 to 1><109 viable cells/ml, assuming a mode of 
application Which Would achieve substantially uniform con 
tact of at least about 50% of the Wheat head. If the antagonists 
are applied as a solid formulation, the rate of application 
should be controlled to result in a comparable number of 
viable cells per unit area of cereal head surface as obtained by 
the aforementioned rates of liquid treatment. 
It is envisioned that the temperatures at Which the antago 
nists are effective Would range from about 5° C. to about 35° 
C. The preferred temperature range is 15-300 C., and the 
optimal range is considered to be 18-280 C. 
The antagonists can theoretically be applied to the seed 
head at any time after the boot stage and before the hard dough 
stage of cereal development. The cereal head is only suscep 
tible to infection by F graminearum from the onset of ?oW 
ering (anthesis) through the soft dough stage of kernel devel 
opment. Thus, the best time to apply the biological control 
agents Would be from the time immediately preceding ?oW 
ering until as late as the soft dough stage of kernel develop 
ment. Application of antagonists to heads before ?owering 
Would alloW antagonists to have coloniZed Wheat head parts 
prior to the Wheat head becoming susceptible to infection. 
Additionally, antagonists Would be Well positioned to colo 
niZe and protect anthers as they emerge from ?orets. HoW 
ever, it is expected that the antagonists Would still be effective 
if applied after ?owering has begun, but before the hard 
dough stage of development. HoWever, it is anticipated that 
long delays may decrease the effectiveness of the treatment 
depending on methods of cell formulation and application. 
The folloWing example is intended only to further illustrate 
the invention and are not intended to limit the scope of the 
invention Which is de?ned by the claims. 
Example 1 
In order to produce prothioconaZole tolerant variants of 
Fusarium head blight antagonist Cryplococcus ?avescens 
OH 182.9 (N RRL Y-30216), pure cultures of the strain Were 
initiated on 1/s strength Tryptic soy broth agar (TSBA) from 
10% glycerol stocks of the strain stored at —800 C. After 24 
hours groWth at 25° C., cells Were transferred to 10 ml of 1/s 
strength Tryptic soy broth (TSB) containing 1 ppm of the 
fungicide prothioconaZole (PTC) in 50 ml Erlenmeyer ?asks 
to obtain an initial optical density (A620) of approximately 
0.100. Flasks Were shaken at 250 rpm and plated after 5 days 
incubation at 250 C. onto 1/5 TSBA+1 ppm PTC. After incu 
bating at 250 C. for several days, plates contained several 
colonies that had obtained a larger siZe than the majority of 
colonies produced on the 1/s TSBA+1 ppm PTC medium. 
Four of these colonies Were selected and streaked for purity 
on 1/s TSBA+1 ppm PTC. The process of liquid culture 
groWth of these 4 putative PTC tolerant variants Was then 
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repeated 4-5 times With the concentration of PTC in the liquid 
and solid media being gradually increased to a ?nal concen 
tration of 5 ppm and the largest colony produced by each of 
the 4 separate variant lines being chosen to start the next cycle 
of groWth in liquid culture containing a slightly higher con 
centration of PTC. 
Each of the 4 variant lines Were then evaluated for equiva 
lence to the Wild type progenitor strain of OH 182.9 based on 
e?icacy in reducing F usarium head blight of Wheat in green 
house tests as folloWs. Hard red spring Wheat (cultivar Norm) 
Was groWn in plant groWth chambers prior to conducting 
plant bioassays on greenhouse benches. Biomass of progeni 
tor strain OH 182.9 and PTCT variants 1C, 3C, 4C and 5C 
Was produced in non-baf?ed, 125 ml Erlenmeyer ?asks con 
taining 25 ml of liquid medium (SDCL, Slininger et al. 2003. 
Postharvest biological control of potato sprouting by 
F usarium dry rot suppressive bacteria. Biocontrol Science 
and Technology. 13:477-494) that Was incubated at 250 rpm, 
2.5 cm orbit and 250 C. for 72 h and diluted to 1A strength With 
dH2O before use. Conidial inoculum of the FHB pathogen 
Gibberella zeae strain Z-3639 Was produced on clari?ed V8 
juice agar under 12 h/day ?uorescent light for 7 days at 240 C. 
At Wheat anthesis, cells of OH 182.9 Were misted onto 
approximately 14 Wheat heads per treatment folloWed imme 
diately by a mist application of a conidial suspension (3x104 
conidia/ml). Heads treated With Water folloWed by the 
conidial suspension served as “pathogen only” controls. 
Plants Were placed in humidity tents for 3 days, scored for 
disease severity after 16 days and log groWth rate in 1/s TSB 
not containing PTC. Disease severity Was determined by 
calculating the average percentage of the surface area of 
individual Wheat heads that exhibit symptoms of infection by 
F graminearum. The variant lines Were also compared for 
total colony forming units per ml (cfu/ml) achieved When 
groWn in 1/s TSB+5 ppm PTC medium. The progenitor strain 
of OH 182.9 does not groW in this medium While all PTC 
tolerant variants of OH 182.9 produced in excess of 5><107 
CFU/ml. 
ProthioconaZole tolerant variants of C. ?avescens OH 
182.9 3C and 4C exhibited signi?cantly greater e?icacy than 
the OH 182.9 parent and Were retained. The results are shoWn 
in Tables 1-3. 
It is understood that the foregoing detailed description is 
given merely by Way of illustration and that modi?cations and 
variations may be made therein Without departing from the 
spirit and scope of the invention. 
TABLE 1 
In?uence of yeast antagonist OH 182.9, prothioconazole tolerant 
variant 4C ofOH 182.9, prothioconazole and combinations thereof on 
F usarium head blight in greenhouse trialsa’ 1’ 
Wheat Cultivar 
Norm 
Change Change Change 
vs vs 100 vs 
Con 
DS Control DI Control KWt trol 
TreatmentC (%) (%) (%) (%) (g) % 
Untreated control 42‘ 0 54‘ 0 3.08 0 
OH 182.9 Wild 27‘B —36 38‘B -30 3.6‘ 20 
Type 
OH 182.9 Variant 7CD -s3 163C -70 4.1‘ 37 
40 
OH 182.9 WT + 1” —98 86 -s5 4.3‘ 37 
Proline 
OH 182.9 40 + OD -100 0C -100 4.1‘ 37 
US 8,241,889 B2 
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TABLE l-continued 
Influence of yeast antagonist OH 182.9, prothioconazole tolerant 
variant 4C of OH 182.9, prothioconazole and combinations thereof on 
F usarium head blight in greenhouse trials‘ 1’ 
1 0 
TABLE 3-continued 
2008 ?eld trial results at Wooster, Ohio: Influence 
ofprothioconaZole, yeast antagonist OH 182.9, prothioconazole 
tolerant variants 3C and 4C of OH 182.9, and combinations 
5 thereof on FHB disease parameters on Winter Wheat cultivar 
Wheat Cultivar Pioneer Brand 2545"’ 1’ 
Norm 
Wheat Cultivar 
Change Change Change Pioneer Brand 
vs vs 100 vs 2545 
Con- 10 
DS Control DI Control KWt trol D5 D1 FDK Yidd TWT DON 
Treatment‘ (%) (%) (%) (%) (g) % Treatmentc (%) (%) (%) bu/A lbs/bu (ppni) 
Proline OH 182.9 30 + 2.5c 8.286 6.386 55.3"‘c 52.4‘B 4.2‘B 
Proline Only OD -100 0c -100 4.0‘ 33 Proline 
P value 0.001 0.001 0.001 15 OH 182.9 40 + 2.8C 8.286 12.5BC 58.5‘ 52.6‘ 3.58 
Proline 
“Within a column, means not followed by the same letter are signi?cantly different (P - 0.05, Proline + WT 2_ 6C 8286 15 JABC 55_6ABC 526A 3 9A8 
Bonferoni mean separation) (24 h (1615 ) 
bDS = Disease severity, D1 = Disease incidence, 100 KWt = One hundred kernel Weight . y C BC C AB AB B 
. . . . . . Proline + 3C 2.3 8.4 2.5 57.1 52.2 3.5 
LProline = Commercial formulation of prothioconazole applied at a rate equivalent to 5 
oz/acre, on 182.9 WT = Wild type strain or on 182.9 (24 h d?l?y) 
20 P value 0.001 0.001 0.001 0.001 0.001 0.001 
“Within a column, means folloWed not folloWed by the same letter are signi?cantly different 
2 < 0.05 Bonferroni mean separation) 
S = Disease severity, D1= Disease incidence, FDK = Fusan'um damaged l<ernels,Yield = 
2008 ?eld trial msults at P?oria, IL: ln?uenc? lliggglsqsieiliéangpshels per acre, TWT = Test Weight expressed in pounds per bushel, DON = 
Ofprothioconazol?, yeast antagonist OH 1829, prothiocon?lol? LProline = Commercial formulation of prothioconazole applied at a rate equivalent to 5 
tolerant variants 3C and 4C ofOH 182.9, and combinations 25 01/8919, OH 182-9 WT = Wild type Strain of OH 182.9 
thereof on FHB disease parameters on Winter Wheat cultivar 
Pioneer Brand 2545"’ b _ 
We claim: 
‘Wheat Cultivar 1. A substantially biologically pure microorganism Which 
hone“ Brand 2545 is a strain of Cij/plococcus?avescens tolerant to prothiocona 
DS D1 100 DON 30 Zole selected from the group consisting of Ciyplococcus?a 
Trpatments (1%,) (1%,) KWT (g) (ppm) vescens 3C Which has been deposited under deposit acces sion 
A A DE A no. NRRL Y-50378, and Cryptococcus?avescens 4C Which 
Untmmd control 8'0 41'3 3'07 11'8 has been de osited under de osit accession no NRRL 
Proline (5 oZ/acre) 15D” 80F 3.57‘B 39Bc P P ' 
OH 182.9 WT 7.6‘B 31.2"?C 2.99’? 13.6‘ Y-50379 
OH 182.9 variant 3C 5.3‘BC 29.6BCD 3.26BCDE 10.4“ 35 2. The microorganism of claim 1 Wherein said strain is said 
- BCD CD CDE BC . . 
OH 182-9 V‘n‘nt 4? 4-6,)” 24-5,, 3- 13 A B C 7-0’; Ciyplococcus?avescens 3C Which has been deposited under 
OH 182.9 3C + Proline 1.4 8.8 3.49 2.3 d -t - Y 40 60” 10.7” 7"?C 4C eposl 81008551011 no; _' ' _ _ _ _ _ 
Proline + WT (24 h 2_3CDEF 10_9EF 3_64A 26C 3. The microorganism of claim 1 Wherein said strain is said 
delay) F F ABCD C Cij/plococcus?avescens 4C (NRRL Which has been depos 
gr‘lm? + 3C (24 h 0-6 4-5 3-43 1-1 40 ited under deposit accession no. NRRL Y-50379. 
e ay . . . . 
P Vahw 0001 0001 0001 0001 4. A method for suppressing Fusarlum head blight in a 
cereal plant comprising applying to a head of said plant at 
“Within a column, means followed not followed by the same letter are signi?cantly different least a microbial antagonj 5t Selected from the group 001151 St 
< 0.05 Bonferroni mean separation) . . . 
S = Disease severity, D1 = Disease incidence, 100 KWT = One hundred kernel Weight, 111g Of CI’yPZOCOCCMS?IIVQSCQHS WhlCh has been depOslted 
DON = Deoxynivalenol ' ' _ _ 
LProline = Commercial formulation of_prothioconazole applied at a rate equivalent to 5 45 under deposlt accesslqn no’ and CWPZOCOC: 
Luz/acre, OH 1829 WT=W1ld type mm of OH 182-9 cus ?avescens 4C Which has been deposited under deposit 
accession no. NRRLY-50379, and combinations thereof, said 
TABLE 3 microbial antagonist being applied in an amount effective to 
reduce the level of Fusarium head blight relative to that in the 
2008 ?eld trial results at Wooster, 011101 Influence 50 corresponding untreated control. 
Of PrOthiOCOH?ZOlQ y??st antagonist OH 1552-9’ prothiocon?lol? 5. The method of claim 4 Wherein said microbial antagonist 
tolerant variants 3C and 4C ofOH 182.9, and combinations is Substantially biologically pure 
thereofon FHB disease parameters on Winter Wheat cultivar 6 Th h d f 1 . 4 h '. .d . b. 1 . 
Pioneer Brand 2545.12 . .' emet o o c aim W erein S211‘ micro 1a antagonist 
is said Cryplococcus?avescens 3C Which has been deposited 
Wheat Cultivar 55 under deposit accession no. NRRL Y-50378. 
P10113654 153mm 7. The method of claim 4 Wherein said microbial antagonist 
is said Cryplococcus?avescens 4C Which has been deposited 
Ds Di FDK Yield TWT DON under deposit accession no. NRRL Y-50379. 
Tr??tm?nt‘ (%) (%) (%) bu/A lbs/bu (PPIH) 8. The method of claim 4 Wherein said microbial antagonist 
Untmmd Control 1192 31 42 4252 MAC 473D 81A 60 is applied to the head prior to hard dough stage of develop 
Proline (5 on 3.5‘?c 113Bc 12.8‘Bc 57.8‘B 51.4‘” 4.0‘B mem 
acre) 9. The method of claim 4 Wherein said microbial antagonist 
OH 182.9 WT 12.6‘ 28.0‘ 29.5"?C 49.43C 49.0‘” 6.8‘B is applied to the head during ?owering 
OH 182.9 variant 9.4‘ 24.3‘B 25.5"?C 49.8"?C 47.7w 6.7‘B . . . . . 3C 10. The method of claim 4 Wherein said microbial antago 
OH 182.9 variant 9.0‘B 22.9‘B 17.4“9c 50.4"‘c 48.2861’ 6.6‘B 65 1115115 applied to the head Prior to ?owering 
4C 11. The method of claim 4 Wherein said cereal is Wheat or 
barley. 
US 8,241,889 B2 
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12. The method of claim 8 wherein said cereal is Wheat. 
13. A composition for suppressing F usarium head blight in 
a cereal plant comprising a microbial antagonist selected 
from the group consisting of Cryplococcus?avescens strain 
3C Which has been deposited under deposit accession no. 
NRRL Y-50378, and Cryplococcus ?avescens strain 4C 
Which has been deposited under deposit accession no. NRRL 
Y-50379, and combinations thereof, in an agronomically 
acceptable carrier. 
14. The composition of claim 13 Which is substantially 
biologically pure. 
12 
15. The composition of claim 13 Wherein said microbial 
antagonist is said Cryplococcus?avescens 3C Which has been 
deposited under deposit accession no. NRRL Y-50378. 
16. The composition of claim 13 Wherein said microbial 
5 antagonist is said Cryplococcus?avescens 4C Which has been 
deposited under deposit accession no. NRRL Y-50379. 
17. The microorganism of claim 1 Which is isolated. 
